The Desensitization Therapy With GB-0998 for Anti-donor Antibody-positive Recipients.
NCT02032095
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
End Stage Renal Disease
Interventions
DRUG:
GB-0998
Sponsor
Japan Blood Products Organization